Back Home Search

KRAS G12C in NSCLC and CRC

    • Protocols

    • UW21051

      OPEN TO ACCRUAL

      Phase 1/2 Study LY3537982 in pts w/KRAS G12-C-Mutant Advanced Solid Tumors